New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in Mice

MLA

Vic Veguilla, et al. “New Pre-Pandemic Influenza Vaccines: An Egg- and Adjuvant-Independent Human Adenoviral Vector Strategy Induces Long-Lasting Protective Immune Responses in Mice.” Clinical Pharmacology & Therapeutics, vol. 82, no. 6, Oct. 2007, pp. 665–71. EBSCOhost, https://doi.org/10.1038/sj.clpt.6100418.

APA

Vic Veguilla, Lakshmi Jayashankar, Mary Hoelscher, Shikha Garg, Suresh K. Mittal, Xuihua Lu, Jacqueline M. Katz, Neetu Singh, & Suryaprakash Sambhara. (2007). New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in Mice. Clinical Pharmacology & Therapeutics, 82(6), 665–671. https://doi.org/10.1038/sj.clpt.6100418

Chicago

Vic Veguilla, Lakshmi Jayashankar, Mary Hoelscher, Shikha Garg, Suresh K. Mittal, Xuihua Lu, Jacqueline M. Katz, Neetu Singh, and Suryaprakash Sambhara. 2007. “New Pre-Pandemic Influenza Vaccines: An Egg- and Adjuvant-Independent Human Adenoviral Vector Strategy Induces Long-Lasting Protective Immune Responses in Mice.” Clinical Pharmacology & Therapeutics 82 (6): 665–71. doi:10.1038/sj.clpt.6100418.